Intervacc
  • About us
    • Management
    • Board of directors
    • Our History
    • Partners
  • Research & Development
    • Pipeline
    • Technology platform
    • Patents
    • Publications
  • Products & Services
    • Vaccines and pharmaceuticals
    • Analyses
  • Investors
    • Market
    • Reports
    • Calendar
    • Rights issue
    • The share
    • Shareholders
    • Certified Adviser
    • Corporate Governance
  • Press
    • Press materials
    • News
    • Legal Press releases
    • Other Press releases
  • Contact
  • Search
  • Swedish

Reports

Click to download Interim report 2025Click to download Annual report 2024Annual report 2023Intermin reports 2022Intermin reports 2021
2025202420232022other
Interim ReportsAnnual reportAnnual reportAnnual report2021,Q1,Q2,Q3,Q4
- January - March- October - December- October - December- October - December
2020,Q1,Q2,Q3,Q4
- July - September- July - September- July - SeptemberAnnual report 2019
- April - June- April - June- April - JuneAnnual report 2018
- January - March- January - March- January - MarchAnnual report 2017
Annual report 2016
Annual report 2015
Annual report 2014
Annual report 2013

Please notice that all financial reports published before September 2020 are in Swedish only

Postal address: Box 112, SE-129 22 Hägersten
Visiting address: Västertorpsvägen 135,
SE-129 44 Hägersten
Phone: 08-120 10 600
Fax: 08-120 10 640
Email: info@intervacc.se